Literature DB >> 5635424

Adenocarcinoma associated with Crohn's disease.

F O Shiel, C G Clark, J C Goligher.   

Abstract

Entities:  

Mesh：

Year:  1968        PMID： 5635424

Source DB:  PubMed          Journal:  Br J Surg        ISSN： 0007-1323            Impact factor:   6.939


× No keyword cloud information.
  5 in total

1.  Carcinoembryonic antigen in patients suffering from ulcerative proctocolitis.

Authors:  A B Mitchell; A M Gill; R T Orchard; R A Parkins
Journal:  Am J Dig Dis       Date:  1975-05

2.  Editorial: Does Crohn's disease predispose to intestinal cancer?

Authors: 
Journal:  Br Med J       Date:  1973-10-06

3.  The Tumor Microenvironment of Bladder Cancer.

Authors:  Ken Hatogai; Randy F Sweis
Journal:  Adv Exp Med Biol       Date:  2020       Impact factor: 2.622

4.  Epigenetic profiling demarcates molecular subtypes of muscle-invasive bladder cancer.

Authors:  K E van der Vos; D J Vis; E Nevedomskaya; Y Kim; W Choi; D McConkey; L F A Wessels; B W G van Rhijn; W Zwart; M S van der Heijden
Journal:  Sci Rep       Date:  2020-07-02       Impact factor: 4.379

5.  Pre-pembrolizumab neutrophil-to-lymphocyte ratio (NLR) predicts the efficacy of second-line pembrolizumab treatment in urothelial cancer regardless of the pre-chemo NLR.

Authors:  Takashi Kobayashi; Katsuhiro Ito; Takahiro Kojima; Satoru Maruyama; Shoichiro Mukai; Masakazu Tsutsumi; Jun Miki; Tomoya Okuno; Yuko Yoshio; Hiroaki Matsumoto; Toru Shimazui; Takehiko Segawa; Takashi Karashima; Kimihiko Masui; Fumimasa Fukuta; Kojiro Tashiro; Kazuto Imai; Shigetaka Suekane; Seiji Nagasawa; Shin Higashi; Tomohiro Fukui; Osamu Ogawa; Hiroshi Kitamura; Hiroyuki Nishiyama
Journal:  Cancer Immunol Immunother       Date:  2021-07-07       Impact factor: 6.968
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.